| Product Name |
Dabigatran Etexilate Mesilate (Ph.Eu. 33.3) Impurity A
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Heterocycles, Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines |
| CAS No |
1408238-40-3 |
| Catalog Number |
GS.01.DAB.01EM |
| Chemical Name/Synonyms |
Etexilate Amide Impurity; Desiminomethyl Carbonyl Dabigatran Etexilate; Ethyl 3-(2-((4-((hexyloxycarbonyl)carbamoyl)phenylamino)methyl)-1-methyl-N- (pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester; Dabigatran Etexilate Related Compound A (USP); |
| Molecular Weight |
628.72 |
| Molecular Formula |
C34H40N6O6 |
| Purity |
NLT 95 % |
| Appearance |
White to Off-White Solid |
| Solubility |
DMSO, Methanol |
| Applications |
Desiminomethyl Carbonyl Dabigatran Etexilate is an impurity of dabigatran etexilate mesylate which is used to treat dangerous blood clots, thereby reducing the risk of stroke, deep vein thrombosis, and pulmonary embolism |
| Inventory Status |
QC Pending
|
